Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments

Results

Naziv:	Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments
Autori:	Feagan, Brian G; Vermeire, Severine; Sandborn, William J; Reinisch, Walter; Tarabar, Dino K; Su, Chinyu; Niezychowski, Wojciech; Zhang, Haiying; Woodworth, Deborah A; Yu, Dahong; Sands, Bruce E;
Godina:	2016
Publikacija:	AMERICAN JOURNAL OF GASTROENTEROLOGY
ISSN:	0002-9270 American Journal of Gastroenterology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 111 str. S319-S320
DOI:	10.14309/00000434-201610001-00709
WoS-ID:	000395764601142
URI:	https://enauka.gov.rs/handle/123456789/815148
Projekat:	Pfizer Inc.
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

2
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall

Google Scholar^TM